Haemonetics Corp (NYSE:HAE)

90.66
Delayed Data
As of May 25
 +0.28 / +0.31%
Today’s Change
38.47
Today|||52-Week Range
91.55
+56.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line16.9M-55.6M-26.3M45.6M
 
 
 
 
 
Depreciation86.1M89.9M89.7M89.2M
 
 
 
 
 
Total Other Cash Flow19.7M114.8M97.3M11.4M
 
 
 
 
 
Funds From Operations126.8M148.1M153.9M140.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-331.0K26.2M-5.8M-80.0M
 
 
 
 
 
Net Cash Flow - Operating Activities127.2M121.9M159.7M220.4M
 
 
 
 
 
 
InvestingCapital Expenditures-122.2M-102.4M-76.1M-74.8M
 
 
 
 
 
Fixed Asset Disposal452.0K637.0K2.8M11.8M
 
 
 
 
 
Other Investing - Uses0.00-3.0M0.000.00
 
 
Net Cash Flow Investing-121.8M-104.8M-73.3M-63.0M
 
 
 
 
 
 
FinancingShort Term Borrowings843.0K2.3M-50.7M671.0K
 
 
 
 
 
Long Term Borrowings-1.0M------
 
 
Long Term Debt Reduction-9.6M-22.3M-42.7M-61.7M
 
 
 
 
 
Net Proceeds Stock Sale14.1M18.4M33.0M40.3M
 
 
 
 
 
Common Preferred Redeemed-39.0M-61.0M0.00-100.0M
 
 
 
 
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing1.6M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-33.2M-62.6M-60.4M-120.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.1M-12.0K-1.6M3.9M
 
 
 
 
 
 
Net Change In Cash-27.8M-45.5M26.0M36.7M